Your browser doesn't support javascript.
loading
Retinoid X Receptor Activation Prevents Diabetic Retinopathy in Murine Models.
Dorofeeva, Iuliia; Zhylkibayev, Assylbek; Saltykova, Irina V; Atigadda, Venkatram; Adhikari, Bibek; Gorbatyuk, Oleg S; Grant, Maria B; Gorbatyuk, Marina S.
Afiliação
  • Dorofeeva I; Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Zhylkibayev A; Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Saltykova IV; Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Atigadda V; Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Adhikari B; Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Gorbatyuk OS; Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Grant MB; Department of Ophthalmology and Vision Sciences, Heersink School of Medicined, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Gorbatyuk MS; Department of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Cells ; 12(19)2023 09 26.
Article em En | MEDLINE | ID: mdl-37830574
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Retinopatia Diabética Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Retinopatia Diabética Idioma: En Ano de publicação: 2023 Tipo de documento: Article